Delivery Order SPE2DB24D3013-SPE2DB25FFMBV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,042.04 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count packages) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designations and carries an ultimate completion date of October 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,396.12 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count units). This competitively awarded, firm fixed price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Xcopri 100 mg tablets (30-count packaging) with a ceiling value of $1,178.96. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a $3,536.88 delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Xcopri 100 mg tablets (30-count units). This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,732.70 delivery order on July 14, 2025, for the supply of Xcopri 100 mg tablets (30-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion on July 15, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains the capacity...
- The Defense Logistics Agency awarded a delivery order valued at $1,768.44 to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count units). This contract was competitively awarded on July 23, 2025, with a firm fixed price structure and an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Xcopri 50 mg tablets (30-count units) with a ceiling value of $13,152.23. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle, carries an ultimate completion date of August 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $3,660.38 to AmerisourceBergen Drug Corp for 30 tablets of Xcopri 100 mg on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $3,274.40 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Xcopri 200 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,357.92 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Xcopri 25 mg tablets (30-count). This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 6, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract involves no set-aside designation and identifies Conshohocken, Pennsylvania, as the place of performance,...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFMBVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,765.44 to AmerisourceBergen Drug Corp for the supply of Xcopri 150 mg tablets (30-count) with a June 3, 2025 completion date. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected to fulfill this medical procurement requirement through open competition. This delivery order represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical commodities such as specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 6/2/25 |